Table 1.

Prognostic scoring systems for myelofibrosis

DIPSSDIPSS plus38 MIPSS70MIPSS70 plusMYSEC39 
Age ☑ ☑ ☑ ☑ ☑ 
Anemia (hemoglobin <10) ☑ ☑ ☑ ☑ ☑ 
WBC >25 ☑ ☑ ☑   
Blast % ☑ ☑ ☑ ☑ ☑ 
Constitutional symptoms ☑ ☑ ☑ ☑ ☑ 
Platelets <100  ☑ ☑  ☑ 
Red cell transfusion dependent  ☑    
Unfavorable karyotype*  ☑  ☑  
Bone marrow fibrosis grade   ☑   
High-risk molecular mutations (1)   ☑ ☑  
High-risk molecular mutations (≥2)   ☑ ☑  
Type 1 CAL-R absence   ☑  ☑ 
Scoring Low risk: 0 Low: 0 Low: 0-1 Low: 0-2 Low: <11 
 Int-1: 1-2 Int-1: 1 Intermediate: 2-4 Intermediate: 3 Int-1: 11-13 
 Int-2: 3-4 Int-2: 2-3 High: ≥5 High: 4-6 Int-2: 14-16 
 High risk: 5-6 High risk: 4-6  Very high: ≥7 High: >16 
DIPSSDIPSS plus38 MIPSS70MIPSS70 plusMYSEC39 
Age ☑ ☑ ☑ ☑ ☑ 
Anemia (hemoglobin <10) ☑ ☑ ☑ ☑ ☑ 
WBC >25 ☑ ☑ ☑   
Blast % ☑ ☑ ☑ ☑ ☑ 
Constitutional symptoms ☑ ☑ ☑ ☑ ☑ 
Platelets <100  ☑ ☑  ☑ 
Red cell transfusion dependent  ☑    
Unfavorable karyotype*  ☑  ☑  
Bone marrow fibrosis grade   ☑   
High-risk molecular mutations (1)   ☑ ☑  
High-risk molecular mutations (≥2)   ☑ ☑  
Type 1 CAL-R absence   ☑  ☑ 
Scoring Low risk: 0 Low: 0 Low: 0-1 Low: 0-2 Low: <11 
 Int-1: 1-2 Int-1: 1 Intermediate: 2-4 Intermediate: 3 Int-1: 11-13 
 Int-2: 3-4 Int-2: 2-3 High: ≥5 High: 4-6 Int-2: 14-16 
 High risk: 5-6 High risk: 4-6  Very high: ≥7 High: >16 
*

Unfavorable karyotype: Complex karyotype or one or two abnormalities that include +8, –7/7q–, i(17q), –5/5q–, 12p–, inv(3), or 11q23. High-Risk molecular mutations: ASXL1, IDH1/2, EZH2, SRSF2, and U2AF1.

Close Modal

or Create an Account

Close Modal
Close Modal